HIMS
As seen on the 24/7 Wall St. homepage on July 23, 2026.
Regular session
$35.24
+13.17%
open $31.14
Hims & Hers Health surged as the telehealth company stands to benefit from ongoing regulatory scrutiny that's keeping compounded GLP-1 competitors off the shelves.
Mentioned: HIMS